Depomed Gets Favorable Nucynta Patent Decision

Depomed Inc. said it received a favorable court decision on its patents for its Nucynta painkiller products and expected the ruling would result in market exclusivity through 2025.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news